The antidepressant sertraline downregulates Akt and has activity against melanoma cells

Pigment Cell & Melanoma Research
Kalpana K ReddyJack L Arbiser

Abstract

Melanoma is a common malignancy which is poorly responsive to chemotherapy and radiation. One of the major reasons melanoma responds poorly to these modalities is constitutive expression of Akt, which protects against apoptosis. The antidepressant sertraline was found to be a potent cytotoxic agent against A375 human melanoma. To determine the mechanism by which sertraline kills melanoma cells, Western blot analysis of signaling molecules, including phosphorylated Akt, caspase 9 and phospho-p70 S6 kinase was performed. Finally, the effects of sertraline on A375 xenografts in mice were assessed. Sertaline potently inhibited the phosphorylation of Akt, and caused cell death through induction of endoplasmic reticulum in vitro. Sertraline monotherapy demonstrated activity against A375 xenografts in vivo. Akt is a major cause of resistance of melanoma to current therapy. Antidepressants are commonly used to prevent interferon-induced depression. Use of antidepressants that decrease Akt may improve the efficacy of interferon and other therapies against melanoma. Further studies are needed to elucidate whether sertraline acts as an Akt inhibitor in melanoma.

References

Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·J L ArbiserJ Folkman
Mar 29, 2001·The New England Journal of Medicine·D L MusselmanA H Miller
Sep 15, 2001·Free Radical Biology & Medicine·F L MeyskensR I Gonzalez
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jack L ArbiserJ David Lambeth
Aug 2, 2002·Cancer Cell·Pamela M Pollock, Paul S Meltzer
Sep 6, 2003·Cancer Cell·David A TuvesonMeenhard Herlyn
May 1, 2004·International Journal of Dermatology·Christina S SanderJens J Thiele
Feb 8, 2005·The Journal of Biological Chemistry·Baskaran GovindarajanJack L Arbiser
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Derek L DaiGang Li
Jun 30, 2005·Cancer Metastasis Reviews·Gavin P Robertson
Jul 22, 2005·Investigational New Drugs·D Scott ErnstMichael Smylie
Oct 20, 2005·Experimental Dermatology·Mara CampioniAlfonso Baldi
Jun 27, 2006·Journal of Immunotherapy·Ajay V MakerSteven A Rosenberg
Oct 5, 2006·Cancer Research·Shian-Ying SungLeland W K Chung
Jan 5, 2007·The International Journal of Neuropsychopharmacology·Jonathan McConathyMichael J Owens
Feb 24, 2007·The Journal of Clinical Investigation·Baskaran GovindarajanJack L Arbiser

❮ Previous
Next ❯

Citations

Sep 23, 2010·Assay and Drug Development Technologies·Christa HahmannThomas Schroeter
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Agnessa Gadeliya GoodsonDouglas Grossman
May 12, 2010·Genetics·Meredith M RaineyEthan O Perlstein
Nov 7, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Si ChenLei Guo
Nov 4, 2009·Journal of Receptor and Signal Transduction Research·Chun-Jen HuangChung-Ren Jan
Aug 31, 2012·Drug and Chemical Toxicology·Ko-Long LinChung-Ren Jan
Oct 27, 2015·Medicine·Hsiang-Lin ChanVincent Chin-Hung Chen
May 27, 2010·International Journal of Cancer. Journal International Du Cancer·Suzanne M Cloonan, David Clive Williams
Mar 5, 2011·Basic & Clinical Pharmacology & Toxicology·Jong-Khing HuangChung-Ren Jan
Feb 2, 2013·Life Sciences·Luciana Romina Frick, Maximiliano Rapanelli
Dec 14, 2011·Cancer Biology & Therapy·SubbaRao V MadhunapantulaGavin P Robertson
Jan 21, 2011·Human & Experimental Toxicology·Jau-Min ChienChung-Ren Jan
Sep 13, 2017·International Journal of Molecular Sciences·Sanguine ByunKi Won Lee
May 2, 2017·Journal of Cardiovascular Pharmacology·Sarah E HaskellRobert D Roghair
Feb 29, 2020·Clinical Epidemiology·Leon Alexander Mclaren BergeTrude E Robsahm
Jan 23, 2019·Current Epidemiology Reports·Monica D'ArcyJennifer L Lund
Aug 24, 2013·Experimental Biology and Medicine·Anna M Bielecka, Ewa Obuchowicz
May 21, 2020·The AAPS Journal·Ali A Alhadab, Richard C Brundage
Jul 10, 2019·American Journal of Therapeutics·Angelita BottegaRosmari Hörner
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Josipa VlainićTomislav Šmuc

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis